{"transactions":[{"id":903284,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2026-02-18T01:16:40.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":10560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026."}],"balance_after":10560,"derivative":{"exercise_price":0,"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":10560},"source":{"system":"sec-edgar","filing":"0000875045-26-000033","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000033/form4.xml","form_type":"4"}},{"id":903283,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2026-02-18T01:16:40.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":3,"price":195.035,"value":585.105,"ownership":{"direct":true},"balance_after":19611.0408,"source":{"system":"sec-edgar","filing":"0000875045-26-000033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000033/form4.xml","form_type":"4"}},{"id":913178,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:03:41.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":4683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025."}],"balance_after":9367,"derivative":{"exercise_price":0,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":4683},"source":{"system":"sec-edgar","filing":"0000875045-26-000022","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000022/form4.xml","form_type":"4"}},{"id":913177,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:03:41.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":1940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":1940,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":1940},"source":{"system":"sec-edgar","filing":"0000875045-26-000022","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000022/form4.xml","form_type":"4"}},{"id":913176,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T22:03:41.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":2102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/8/2023."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":2102},"source":{"system":"sec-edgar","filing":"0000875045-26-000022","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000022/form4.xml","form_type":"4"}},{"id":913175,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2026-02-10T22:03:41.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1408,"price":201.18,"value":283261.44,"ownership":{"direct":true},"balance_after":19608.0408,"source":{"system":"sec-edgar","filing":"0000875045-26-000022","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000022/form4.xml","form_type":"4"}},{"id":913174,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2026-02-10T22:03:41.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":4683,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":21016.0408,"source":{"system":"sec-edgar","filing":"0000875045-26-000022","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000022/form4.xml","form_type":"4"}},{"id":913173,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2026-02-10T22:03:41.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":914,"price":201.18,"value":183878.52,"ownership":{"direct":true},"balance_after":16333.0408,"source":{"system":"sec-edgar","filing":"0000875045-26-000022","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000022/form4.xml","form_type":"4"}},{"id":913172,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2026-02-10T22:03:41.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":1940,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17247.0408,"source":{"system":"sec-edgar","filing":"0000875045-26-000022","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000022/form4.xml","form_type":"4"}},{"id":913171,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2026-02-10T22:03:41.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1017,"price":201.18,"value":204600.06,"ownership":{"direct":true},"balance_after":15307.0408,"source":{"system":"sec-edgar","filing":"0000875045-26-000022","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000022/form4.xml","form_type":"4"}},{"id":913170,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2026-02-10T22:03:41.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":2102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 166.6667 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2025."}],"balance_after":16324.0408,"source":{"system":"sec-edgar","filing":"0000875045-26-000022","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000022/form4.xml","form_type":"4"}},{"id":1272577,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2025-02-12T22:47:12.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":false,"shares":2272,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":2272},"source":{"system":"sec-edgar","filing":"0001127602-25-004461","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004461/form4.xml","form_type":"4"}},{"id":1272576,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2025-02-12T22:47:12.000Z","date":"2025-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":670,"price":142.54,"value":95501.8,"ownership":{"direct":true},"balance_after":14055.3741,"source":{"system":"sec-edgar","filing":"0001127602-25-004461","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004461/form4.xml","form_type":"4"}},{"id":1272575,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2025-02-12T22:47:12.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":true,"shares":2272,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14725.3741,"source":{"system":"sec-edgar","filing":"0001127602-25-004461","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004461/form4.xml","form_type":"4"}},{"id":1277533,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T23:47:07.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":false,"shares":1940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":3880,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":1940},"source":{"system":"sec-edgar","filing":"0001127602-25-003957","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003957/form4.xml","form_type":"4"}},{"id":1277532,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T23:47:07.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":false,"shares":2102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/8/2023."}],"balance_after":2102,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":2102},"source":{"system":"sec-edgar","filing":"0001127602-25-003957","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003957/form4.xml","form_type":"4"}},{"id":1277531,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T23:47:07.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":14050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025."}],"balance_after":14050,"derivative":{"exercise_price":0,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":14050},"source":{"system":"sec-edgar","filing":"0001127602-25-003957","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003957/form4.xml","form_type":"4"}},{"id":1277530,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2025-02-10T23:47:07.000Z","date":"2025-02-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":603,"price":141.35,"value":85234.05,"ownership":{"direct":true},"balance_after":12453.3741,"source":{"system":"sec-edgar","filing":"0001127602-25-003957","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003957/form4.xml","form_type":"4"}},{"id":1277529,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2025-02-10T23:47:07.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":true,"shares":1940,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13056.3741,"source":{"system":"sec-edgar","filing":"0001127602-25-003957","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003957/form4.xml","form_type":"4"}},{"id":1277528,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2025-02-10T23:47:07.000Z","date":"2025-02-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":620,"price":141.35,"value":87637.0,"ownership":{"direct":true},"balance_after":11116.3741,"source":{"system":"sec-edgar","filing":"0001127602-25-003957","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003957/form4.xml","form_type":"4"}},{"id":1277527,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2025-02-10T23:47:07.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":true,"shares":2102,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11736.3741,"source":{"system":"sec-edgar","filing":"0001127602-25-003957","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003957/form4.xml","form_type":"4"}},{"id":1551551,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2024-04-04T00:11:14.000Z","date":"2024-04-01","kind":"exercise","planned":false,"acquired":false,"shares":240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award was granted to the reporting person on April 1, 2021. The final portion of the awards vested on the third anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2024-04-01","underlying":"Common Stock","underlying_shares":240},"source":{"system":"sec-edgar","filing":"0001127602-24-012405","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224012405/form4.xml","form_type":"4"}},{"id":1551550,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2024-04-04T00:11:14.000Z","date":"2024-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":117,"price":214.83,"value":25135.11,"ownership":{"direct":true},"balance_after":9634.3741,"source":{"system":"sec-edgar","filing":"0001127602-24-012405","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224012405/form4.xml","form_type":"4"}},{"id":1551549,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2024-04-04T00:11:14.000Z","date":"2024-04-01","kind":"exercise","planned":false,"acquired":true,"shares":240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"1. Includes 93.3846 shares acquired under the Biogen Inc. employee stock purchase plan on 3/28/2024."}],"balance_after":9751.3741,"source":{"system":"sec-edgar","filing":"0001127602-24-012405","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224012405/form4.xml","form_type":"4"}},{"id":1630972,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2024-02-22T02:28:30.000Z","date":"2024-02-16","kind":"other","planned":false,"acquired":false,"shares":504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021. The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":504},"source":{"system":"sec-edgar","filing":"0001127602-24-006213","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006213/form4.xml","form_type":"4"}},{"id":1630971,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2024-02-22T02:28:30.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":false,"shares":404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021. The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":504,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":404},"source":{"system":"sec-edgar","filing":"0001127602-24-006213","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006213/form4.xml","form_type":"4"}},{"id":1630970,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Performance Stock Unit","published_at":"2024-02-22T02:28:30.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":false,"shares":856,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2024-02-18","expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":856},"source":{"system":"sec-edgar","filing":"0001127602-24-006213","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006213/form4.xml","form_type":"4"}},{"id":1630969,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2024-02-22T02:28:30.000Z","date":"2024-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":196,"price":219.08,"value":42939.68,"ownership":{"direct":true},"balance_after":9417.9895,"source":{"system":"sec-edgar","filing":"0001127602-24-006213","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006213/form4.xml","form_type":"4"}},{"id":1630968,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2024-02-22T02:28:30.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":true,"shares":404,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9613.9895,"source":{"system":"sec-edgar","filing":"0001127602-24-006213","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006213/form4.xml","form_type":"4"}},{"id":1630967,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2024-02-22T02:28:30.000Z","date":"2024-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":414,"price":219.08,"value":90699.12,"ownership":{"direct":true},"balance_after":9209.9895,"source":{"system":"sec-edgar","filing":"0001127602-24-006213","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006213/form4.xml","form_type":"4"}},{"id":1630966,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2024-02-22T02:28:30.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":true,"shares":856,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9623.9895,"source":{"system":"sec-edgar","filing":"0001127602-24-006213","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006213/form4.xml","form_type":"4"}},{"id":1647466,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2024-02-13T23:04:21.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":false,"shares":2272,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":2272,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":2272},"source":{"system":"sec-edgar","filing":"0001127602-24-004800","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004800/form4.xml","form_type":"4"}},{"id":1647465,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2024-02-13T23:04:21.000Z","date":"2024-02-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":761,"price":240.98,"value":183385.78,"ownership":{"direct":true},"balance_after":8767.9895,"source":{"system":"sec-edgar","filing":"0001127602-24-004800","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004800/form4.xml","form_type":"4"}},{"id":1647464,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2024-02-13T23:04:21.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":true,"shares":2272,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9528.9895,"source":{"system":"sec-edgar","filing":"0001127602-24-004800","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004800/form4.xml","form_type":"4"}},{"id":1652212,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2024-02-10T01:01:09.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":false,"shares":2101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/8/2023."}],"balance_after":4204,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":2101},"source":{"system":"sec-edgar","filing":"0001127602-24-004304","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004304/form4.xml","form_type":"4"}},{"id":1652211,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2024-02-10T01:01:09.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":5820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":5820,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":5820},"source":{"system":"sec-edgar","filing":"0001127602-24-004304","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004304/form4.xml","form_type":"4"}},{"id":1652210,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2024-02-10T01:01:09.000Z","date":"2024-02-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":638,"price":240.3,"value":153311.4,"ownership":{"direct":true},"balance_after":7256.9895,"source":{"system":"sec-edgar","filing":"0001127602-24-004304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004304/form4.xml","form_type":"4"}},{"id":1652209,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2024-02-10T01:01:09.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":true,"shares":2101,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7894.9895,"source":{"system":"sec-edgar","filing":"0001127602-24-004304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004304/form4.xml","form_type":"4"}},{"id":1665791,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Performance Stock Unit","published_at":"2024-01-31T22:35:40.000Z","date":"2024-01-29","kind":"grant","planned":false,"acquired":true,"shares":856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 18, 2021. The PSUs will vest on February 18, 2024."}],"balance_after":856,"derivative":{"exercise_price":0,"exercise_date":"2024-02-18","expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":856},"source":{"system":"sec-edgar","filing":"0001127602-24-002812","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224002812/form4.xml","form_type":"4"}},{"id":1930512,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2023-04-04T21:21:24.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":false,"shares":239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award was granted to the reporting person on April 1, 2021. The remaining portion of the award vests in equal installments on each of the second and third anniversary of the grant date."}],"balance_after":240,"derivative":{"exercise_price":0,"expiration_date":"2024-04-01","underlying":"Common Stock","underlying_shares":239},"source":{"system":"sec-edgar","filing":"0001127602-23-012361","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223012361/form4.xml","form_type":"4"}},{"id":1930511,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2023-04-04T21:21:24.000Z","date":"2023-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":116,"price":278.03,"value":32251.48,"ownership":{"direct":true},"balance_after":5702.2903,"source":{"system":"sec-edgar","filing":"0001127602-23-012361","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223012361/form4.xml","form_type":"4"}},{"id":1930510,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2023-04-04T21:21:24.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":true,"shares":239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 91.6992 shares acquired under the Biogen Inc. employee stock purchase plan."}],"balance_after":5818.2903,"source":{"system":"sec-edgar","filing":"0001127602-23-012361","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223012361/form4.xml","form_type":"4"}},{"id":2001585,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2023-02-22T22:06:22.000Z","date":"2023-02-17","kind":"other","acquired":false,"shares":426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021. The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":908,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":426},"source":{"system":"sec-edgar","filing":"0001127602-23-006524","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006524/form4.xml","form_type":"4"}},{"id":2001584,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2023-02-22T22:06:22.000Z","date":"2023-02-17","kind":"exercise","acquired":false,"shares":480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021. The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":1334,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":480},"source":{"system":"sec-edgar","filing":"0001127602-23-006524","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006524/form4.xml","form_type":"4"}},{"id":2001583,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2023-02-22T22:06:22.000Z","date":"2023-02-17","kind":"tax_withholding","acquired":false,"shares":233,"price":278.38,"value":64862.54,"ownership":{"direct":true},"balance_after":5099.2903,"source":{"system":"sec-edgar","filing":"0001127602-23-006524","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006524/form4.xml","form_type":"4"}},{"id":2001582,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2023-02-22T22:06:22.000Z","date":"2023-02-17","kind":"exercise","acquired":true,"shares":480,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5579.2903,"source":{"system":"sec-edgar","filing":"0001127602-23-006524","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006524/form4.xml","form_type":"4"}},{"id":2017902,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2023-02-15T02:23:45.000Z","date":"2023-02-10","kind":"other","acquired":false,"shares":416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award was granted to the reporting person on February 12, 2020. The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":416},"source":{"system":"sec-edgar","filing":"0001127602-23-005268","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005268/form4.xml","form_type":"4"}},{"id":2017901,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2023-02-15T02:23:45.000Z","date":"2023-02-10","kind":"exercise","acquired":false,"shares":340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award was granted to the reporting person on February 12, 2020. The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":416,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":340},"source":{"system":"sec-edgar","filing":"0001127602-23-005268","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005268/form4.xml","form_type":"4"}},{"id":2017900,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2023-02-15T02:23:45.000Z","date":"2023-02-10","kind":"exercise","acquired":false,"shares":2271,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":4544,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":2271},"source":{"system":"sec-edgar","filing":"0001127602-23-005268","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005268/form4.xml","form_type":"4"}},{"id":2017899,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2023-02-15T02:23:45.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":165,"price":286.3,"value":47239.5,"ownership":{"direct":true},"balance_after":5332.2903,"source":{"system":"sec-edgar","filing":"0001127602-23-005268","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005268/form4.xml","form_type":"4"}},{"id":2017898,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2023-02-15T02:23:45.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":537,"price":286.3,"value":153743.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy the withholding tax liability due upon vesting of shares, as previously disclosed by reporting person on January 27, 2023."}],"balance_after":5497.2903,"source":{"system":"sec-edgar","filing":"0001127602-23-005268","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005268/form4.xml","form_type":"4"}},{"id":2017897,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2023-02-15T02:23:45.000Z","date":"2023-02-10","kind":"exercise","acquired":true,"shares":340,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6034.2903,"source":{"system":"sec-edgar","filing":"0001127602-23-005268","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005268/form4.xml","form_type":"4"}},{"id":2017896,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2023-02-15T02:23:45.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":685,"price":286.3,"value":196115.5,"ownership":{"direct":true},"balance_after":5694.2903,"source":{"system":"sec-edgar","filing":"0001127602-23-005268","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005268/form4.xml","form_type":"4"}},{"id":2017895,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2023-02-15T02:23:45.000Z","date":"2023-02-10","kind":"exercise","acquired":true,"shares":2271,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6379.2903,"source":{"system":"sec-edgar","filing":"0001127602-23-005268","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005268/form4.xml","form_type":"4"}},{"id":2023669,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2023-02-10T23:53:01.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":6305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/8/2023."}],"balance_after":6305,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":6305},"source":{"system":"sec-edgar","filing":"0001127602-23-004582","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223004582/form4.xml","form_type":"4"}},{"id":2044274,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2023-01-27T22:59:24.000Z","date":"2023-01-25","kind":"grant","acquired":true,"shares":1340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 12, 2020. The shares will vest on February 12, 2023."}],"balance_after":4108.2903,"source":{"system":"sec-edgar","filing":"0001127602-23-002483","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223002483/form4.xml","form_type":"4"}},{"id":2095003,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2022-12-06T23:33:25.000Z","date":"2022-12-02","kind":"exercise","acquired":false,"shares":131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on December 2, 2019 and vested in three equal installments on each anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2022-12-02","underlying":"Common Stock","underlying_shares":131},"source":{"system":"sec-edgar","filing":"0001127602-22-026992","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222026992/form4.xml","form_type":"4"}},{"id":2095002,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2022-12-06T23:33:25.000Z","date":"2022-12-02","kind":"tax_withholding","acquired":false,"shares":39,"price":298.9,"value":11657.1,"ownership":{"direct":true},"balance_after":2768.2903,"source":{"system":"sec-edgar","filing":"0001127602-22-026992","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222026992/form4.xml","form_type":"4"}},{"id":2095001,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2022-12-06T23:33:25.000Z","date":"2022-12-02","kind":"exercise","acquired":true,"shares":131,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2807.2903,"source":{"system":"sec-edgar","filing":"0001127602-22-026992","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222026992/form4.xml","form_type":"4"}},{"id":2196546,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2022-08-03T21:40:39.000Z","date":"2022-08-01","kind":"exercise","acquired":false,"shares":825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This award was granted to the reporting person on August 1, 2019 and vested in full on August 1, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2022-08-01","underlying":"Common Stock","underlying_shares":825},"source":{"system":"sec-edgar","filing":"0001127602-22-020415","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222020415/form4.xml","form_type":"4"}},{"id":2196545,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2022-08-03T21:40:39.000Z","date":"2022-08-01","kind":"exercise","acquired":false,"shares":255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award was granted to the reporting person on August 1, 2019. The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting,\nwhich is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of\nshares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of\nvested shares = number of shares at target payout times (the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price\nfollowing and including the grant date))."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2022-08-01","underlying":"Common Stock","underlying_shares":255},"source":{"system":"sec-edgar","filing":"0001127602-22-020415","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222020415/form4.xml","form_type":"4"}},{"id":2196544,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2022-08-03T21:40:39.000Z","date":"2022-08-01","kind":"other","acquired":false,"shares":299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award was granted to the reporting person on August 1, 2019. The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting,\nwhich is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of\nshares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of\nvested shares = number of shares at target payout times (the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price\nfollowing and including the grant date))."}],"balance_after":255,"derivative":{"exercise_price":0,"expiration_date":"2022-08-01","underlying":"Common Stock","underlying_shares":299},"source":{"system":"sec-edgar","filing":"0001127602-22-020415","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222020415/form4.xml","form_type":"4"}},{"id":2196543,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2022-08-03T21:40:39.000Z","date":"2022-08-01","kind":"tax_withholding","acquired":false,"shares":243,"price":209.26,"value":50850.18,"ownership":{"direct":true},"balance_after":2676.2903,"source":{"system":"sec-edgar","filing":"0001127602-22-020415","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222020415/form4.xml","form_type":"4"}},{"id":2196542,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2022-08-03T21:40:39.000Z","date":"2022-08-01","kind":"exercise","acquired":true,"shares":825,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2919.2903,"source":{"system":"sec-edgar","filing":"0001127602-22-020415","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222020415/form4.xml","form_type":"4"}},{"id":2196541,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2022-08-03T21:40:39.000Z","date":"2022-08-01","kind":"tax_withholding","acquired":false,"shares":76,"price":209.26,"value":15903.76,"ownership":{"direct":true},"balance_after":2094.2903,"source":{"system":"sec-edgar","filing":"0001127602-22-020415","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222020415/form4.xml","form_type":"4"}},{"id":2196540,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2022-08-03T21:40:39.000Z","date":"2022-08-01","kind":"exercise","acquired":true,"shares":255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 102.4003 shares acquired under the Biogen Inc. employee stock purchase plan."}],"balance_after":2170.2903,"source":{"system":"sec-edgar","filing":"0001127602-22-020415","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222020415/form4.xml","form_type":"4"}},{"id":2306093,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2022-04-05T21:44:59.000Z","date":"2022-04-01","kind":"exercise","acquired":false,"shares":239,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit is converted to one share of common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award was granted to the reporting person on April 1, 2021 and vested with respect to 239 shares on April 1, 2022.  The remaining portion of the award vests in equal installments on each of the second and third anniversary of the grant date."}],"balance_after":479,"derivative":{"exercise_price":0,"expiration_date":"2024-04-01","underlying":"Common Stock","underlying_shares":239},"source":{"system":"sec-edgar","filing":"0001127602-22-011610","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222011610/form4.xml","form_type":"4"}},{"id":2306092,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2022-04-05T21:44:59.000Z","date":"2022-04-01","kind":"tax_withholding","acquired":false,"shares":84,"price":210.65,"value":17694.6,"ownership":{"direct":true},"balance_after":1812.89,"source":{"system":"sec-edgar","filing":"0001127602-22-011610","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222011610/form4.xml","form_type":"4"}},{"id":2306091,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2022-04-05T21:44:59.000Z","date":"2022-04-01","kind":"exercise","acquired":true,"shares":239,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit is converted to one share of common stock upon vesting."}],"balance_after":1896.89,"source":{"system":"sec-edgar","filing":"0001127602-22-011610","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222011610/form4.xml","form_type":"4"}},{"id":2380145,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2022-02-23T21:20:19.000Z","date":"2022-02-18","kind":"other","acquired":false,"shares":535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021. The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":1814,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":535},"source":{"system":"sec-edgar","filing":"0001127602-22-006278","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006278/form4.xml","form_type":"4"}},{"id":2380144,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2022-02-23T21:20:19.000Z","date":"2022-02-18","kind":"exercise","acquired":false,"shares":371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021. The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":2349,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":371},"source":{"system":"sec-edgar","filing":"0001127602-22-006278","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006278/form4.xml","form_type":"4"}},{"id":2380143,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2022-02-23T21:20:19.000Z","date":"2022-02-18","kind":"tax_withholding","acquired":false,"shares":110,"price":209.79,"value":23076.9,"ownership":{"direct":true},"balance_after":1657.89,"source":{"system":"sec-edgar","filing":"0001127602-22-006278","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006278/form4.xml","form_type":"4"}},{"id":2380142,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2022-02-23T21:20:19.000Z","date":"2022-02-18","kind":"exercise","acquired":true,"shares":371,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1767.89,"source":{"system":"sec-edgar","filing":"0001127602-22-006278","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006278/form4.xml","form_type":"4"}},{"id":2395603,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:11:47.000Z","date":"2022-02-12","kind":"other","acquired":false,"shares":489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 12, 2020. The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":756,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":489},"source":{"system":"sec-edgar","filing":"0001127602-22-004984","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004984/form4.xml","form_type":"4"}},{"id":2395602,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:11:47.000Z","date":"2022-02-12","kind":"exercise","acquired":false,"shares":263,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 12, 2020. The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":1245,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":263},"source":{"system":"sec-edgar","filing":"0001127602-22-004984","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004984/form4.xml","form_type":"4"}},{"id":2395601,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2022-02-15T21:11:47.000Z","date":"2022-02-12","kind":"tax_withholding","acquired":false,"shares":92,"price":214.59,"value":19742.28,"ownership":{"direct":true},"balance_after":1396.89,"source":{"system":"sec-edgar","filing":"0001127602-22-004984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004984/form4.xml","form_type":"4"}},{"id":2395600,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Common Stock","published_at":"2022-02-15T21:11:47.000Z","date":"2022-02-12","kind":"exercise","acquired":true,"shares":263,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1488.89,"source":{"system":"sec-edgar","filing":"0001127602-22-004984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004984/form4.xml","form_type":"4"}},{"id":2399479,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66328,"kind":"person","name":"Murphy Nicole","position":1,"cik":"0001910644","reported_name":"Murphy Nicole","relationship":{"officer":true,"officer_title":"Head of Pharm Ops and Tech"}}],"security":"Restricted Stock Unit","published_at":"2022-02-14T21:21:08.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":6815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":6815,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":6815},"source":{"system":"sec-edgar","filing":"0001127602-22-004784","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004784/form4.xml","form_type":"4"}}]}